JPLA
RIGL icon

Joseph P. Lucia & Associates’s Rigel Pharmaceuticals RIGL Stock Holding History

Joseph P. Lucia & Associates’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15
Closed -$1K – 459
2021
Q3 		$1K Hold
15
– – ﹤0.01% 559
2021
Q2 		$1K Hold
15
– – ﹤0.01% 552
2021
Q1 		$1K Hold
15
– – ﹤0.01% 545
2020
Q4 		$1K Buy
+15
New +$434 ﹤0.01% 469

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Joseph P. Lucia & Associates's RIGL Position: Q4 2021 in Review

Joseph P. Lucia & Associates sold out of Rigel Pharmaceuticals (RIGL) in Q4 2021, closing a stake of 15 shares — an estimated $1K sold.

Joseph P. Lucia & Associates first reported a position in RIGL in Q4 2020 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 162 funds tracked by Wall St. Rank hold RIGL as of Q4 2021.

  • Joseph P. Lucia & Associates reported no remaining Rigel Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 15 Rigel Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Joseph P. Lucia & Associates first reported a position in Rigel Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Joseph P. Lucia & Associates's Rigel Pharmaceuticals position peaked at $1K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2021.

Based on Joseph P. Lucia & Associates's 13F filing for Q4 2021, filed 4 Feb 2022.